NEW YORK (GenomeWeb) Cancer Genetics and Mendel Health announced today that they have formed a strategic alliance to combine their respective cancer clinical trial matching platforms.

Under the terms of the deal, the companies will incorporate Mendel's deep-learning engine called Mendel.ai in CGI's disease-focused reports and testing results. An initial version of the system is expected to be available to early-access partners in the second quarter of this year, with a wider rollout later in 2017, they said.

Registering provides access to this and other free content.

Already have an account? .

Go here to see the original:
Cancer Genetics, Mendel Health Partner on Clinical Trial Matching Tech - GenomeWeb